retatrutide fat loss clinical trial results Results: How Much Weight Can You Lose & How Quick? Difference between tirzepatide and retatrutide:

Responses can vary based on individual factors such as genetics, metabolism, lifestyle, and overall health history

The EUA is for individuals 12 years and older

Generally adults with BMI 30, or 27 with weightrelated conditions (like prediabetes, hypertension, or dyslipidemia), who have tried lifestyle changes and are ready for a structured medical program

It is noteworthy that GIPR agonism can also attenuate PYY mediated nausea in preclinical models ( Figure 4 5 Conclusions Incretin receptor agonists including GLP-1R agonists and dual GLP-1R/GIPR co-agonists reduce food intake and drive weight loss in patients with obesity

Hydration is also critical

Hair shedding has been reported by some people taking GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound